News | December 04, 2014

Chesapeake Urology Improves Prostate Cancer Detection and Diagnosis With 3-D Ultrasound/MRI Fusion Biopsy

More than 500 prostate biopsies have been performed utilizing this technology

biopsy systems, prostate, 3-d technology

December 4, 2014 — Chesapeake Urology Associates offers a state-of-the-art prostate cancer diagnostic, which fuses detailed MRI scans with live, real-time ultrasound images of the prostate. This biopsy system provides Chesapeake urologists with the capability to pinpoint tumors within the prostate gland, leading to more targeted treatment planning and better outcomes.

By combining advanced MRI imaging with 3-D ultrasound technology, this new biopsy system:

  • Creates a 3-D map of the prostate
  • Identifies suspicious lesions or targets on MRI
  • Fuses or overlaps the 3-D MRI image onto the real-time 3-D ultrasound image of the prostate
  • Provides clear visualization of the biopsy needle and the targeted lesion for accurate guidance
  • Stores the exact location of each biopsy sample for future referencebopsy

 

Unlike the standard 2-D TRUS-guided prostate biopsy, which takes random tissue samples from the prostate and has a higher rate of missing cancerous cells within the gland, the 3-D Ultrasound/MRI Fusion Biopsy combines the clarity of an MRI image with a 3-D ultrasound image. This creates an enhanced 3-D map of the prostate for improved visualization of the gland, allowing determination of the exact location of potential tumors.

For more information: www.chesapeakeurology.com

Related Content

Blue Earth Diagnostics Expands Access to Axumin in Europe
News | Radiopharmaceuticals and Tracers | May 13, 2019
Blue Earth Diagnostics announced expanded access to the Axumin (fluciclovine (18F)) imaging agent in Europe. The first...
Artificial Intelligence Performs As Well As Experienced Radiologists in Detecting Prostate Cancer
News | Artificial Intelligence | April 18, 2019
University of California Los Angeles (UCLA) researchers have developed a new artificial intelligence (AI) system to...
News | Biopsy Systems | March 29, 2019
Dune Medical Devices has just completed the first in-man cases for Smart Biopsy, its percutaneous soft tissue biopsy...
Houston Methodist Hospital Acquires Focal One High-Intensity Focused Ultrasound System
News | Focused Ultrasound Therapy | March 19, 2019
EDAP TMS SA announced that Houston Methodist Hospital, one of the first hospitals in the U.S. to offer Ablatherm...
Mississippi Cancer Center Combines RayStation and TomoTherapy for Prostate Cancer Case
News | Treatment Planning | March 08, 2019
Anderson Regional Cancer Center in Meridian, Miss., has treated its first patient using the combination of RaySearch's...
FDA Clears Ion Endoluminal Lung Biopsy System
Technology | Interventional Radiology | February 20, 2019
The U.S. Food and Drug Administration (FDA) cleared the Ion endoluminal system from Intuitive Surgical Inc. to enable...
Micro-Ultrasound and Artificial Intelligence Combining to Detect Prostate Cancer
News | Prostate Cancer | February 12, 2019
Cambridge Consultants has partnered with Exact Imaging, makers of the ExactVu micro-ultrasound platform, as the two...
Southern Asia's First Proton Therapy Center Begins Treatments
News | Proton Therapy | January 28, 2019
IBA (Ion Beam Applications SA) announced the opening of the Apollo Proton Cancer Centre in Chennai, India, and the...
Novel Technique May Significantly Reduce Breast Biopsies
News | Breast Biopsy Systems | January 17, 2019
A novel technique that uses mammography to determine the biological tissue composition of a tumor could help reduce...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...